mail
versión imprimible
 
 

3rd Dry AMD Therapeutics Summit

Evvnt Promotion / evvnt
-
30.11.2022 - 02.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 07:50 - 12:00
 
Temas de la conferencia
2022 hosts the race between IVERIC Bio and Apellis for regulatory approval of the very first marketable dry AMD treatment. In addition to clinical advances, the field will see plenty of technology advances for more patient-compliant therapeutics, with the favourable one-dose gene therapy approach addition to pipelines, and optimized biomarker technology.

Join our 30+ expert speakers as we tackle the most critical roadblocks preventing your drugs getting the patients who need them.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/1279770-3?pid=4832

Speakers: Abraham Scaria | Chief Scientific Officer | AGTC, Anneke Der Hollander | Senior Principal Scientist and Ophthalmology Lead | AbbVie, and more.
 

Información e inscripción:

https://go.evvnt.com/1279770-2?pid=4832
Ms. Stephanie Nketia
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 3997.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk AustriaÖsterreichische Akademie der ÄrztenewTreeÖsterreichische Gesellschaft für Public HealthAlumni Club Medizinische Universität Wien